Syamel Muhammad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Syamel Muhammad has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Allen Gideon Tan
Department of Obstetrics and Gynecology, University of the Philippines Manila, Manila, Philippines
3 shared publications - Angela Cho
Department of Obstetrics and Gynecology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea
3 shared publications - Biswajit Dash
Department of Gynecological Oncology, Tata Memorial Hospital, HBNI University, Mumbai, India
3 shared publications - Christine Shan-Chi Chiu
Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
3 shared publications - Doris R. Benavides
Department of Obstetrics and Gynecology, University of the Philippines Manila, Manila, Philippines
3 shared publications - Emiri Miyamoto
Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan
3 shared publications
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Current status of fertility preservation for borderline ovarian tumor in Asian regions: results from ASGO-special task force for fertility preservation; part I. Fertility-sparing treatment for borderline ovarian tumor
Kuji S, et al. J Gynecol Oncol. 2027 ;38:e24. https://doi.org/10.3802/jgo.2027.38.e24
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Open AccessCurrent status of fertility preservation for borderline ovarian tumor in Asian regions: results from ASGO-special task force for fertility preservation; part I. Fertility-sparing treatment for borderline ovarian tumor
Kuji S, et al. J Gynecol Oncol. 2027 ;38:e24. https://doi.org/10.3802/jgo.2027.38.e24
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Current status of fertility preservation for borderline ovarian tumor in Asian countries: results from ASGO-special task force for fertility preservation; part II. Fertility and pregnancy planning following initial treatment
Kuji S, et al. J Gynecol Oncol. 2027 ;38:e21. https://doi.org/10.3802/jgo.2027.38.e21
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Open AccessCurrent status of fertility preservation for borderline ovarian tumor in Asian countries: results from ASGO-special task force for fertility preservation; part II. Fertility and pregnancy planning following initial treatment
Kuji S, et al. J Gynecol Oncol. 2027 ;38:e21. https://doi.org/10.3802/jgo.2027.38.e21
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
The real-world practice of fertility preservation for patients with epithelial ovarian cancer in Asian regions
Yoshihara M, et al. J Gynecol Oncol. 2027 ;38:e17. https://doi.org/10.3802/jgo.2027.38.e17
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Open AccessThe real-world practice of fertility preservation for patients with epithelial ovarian cancer in Asian regions
Yoshihara M, et al. J Gynecol Oncol. 2027 ;38:e17. https://doi.org/10.3802/jgo.2027.38.e17
- Open Access
- 13 August 2026
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 10 (2) , 365-374
Correlation Between BRCA Mutation And Lymphatic Node Involvement In Advanced Stage Ovarian Cancer
Background Gene mutations affecting the Breast Cancer-1 (BRCA1) and Breast Cancer-2 (BRCA2) genes are linked to ovarian and breast cancer which connected with a risk of ovarian cancer of 50% and 20%, respectively. High-grade serous ovarian cancer (HGSC) frequently has lymph node involvement. According to lymphatic drainage routes, the most prevalent site of nodal metastases is in the aortic area. A case of Cancer of Unknown Primary (CUP) with abdominal lymph node enlargement and high carbohydrate antigen 125 levels discovered a germline Breast Cancer 1 (BRCA1) p.L63* variant by a family history inquiry and BRCA analysis, indicating hereditary breast and ovarian cancer syndrome. Therefore we wanted to assess whether BRCA gene status correlates with lymph node involvement in advanced stage ovarian cancer. Methods This was an analytic-observational study with cross sectional study design. The samples in this study were patients diagnosed with advanced stage ovarian cancer who were treated at M Djamil Padang General Hospital, Ibnu Sina Hospital Padang, and Ahmad Mochtar Hospital Bukittinggi by using data from BRCA somatic test results and anatomical pathology examination results. Data were being tested statistically with Chi-square/ Fischer test. Result this study showed 1 patient (3,1%) with positive pathogenic mutation detected in BRCA1 gen with lymphatic node involvement, and 8 (25%) patients without lymphatic node involvement. This study also showed 3 patients (9,4%) with negative pathogenic mutation detected in BRCA1 gen with lymphatic node involvement, and 20 (62,5%) patients without lymphatic node involvement. There is no significant correlation between BRCA mutation and lymphatic node involvement in advanced stage ovarian cancer (p=1,0). Conclusion BRCA mutation has no significant correlation with lymphatic node involvement in advanced stage ovarian cancer.
- 13 August 2026
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 10 (2) , 365-374
Open AccessCorrelation Between BRCA Mutation And Lymphatic Node Involvement In Advanced Stage Ovarian Cancer
Background Gene mutations affecting the Breast Cancer-1 (BRCA1) and Breast Cancer-2 (BRCA2) genes are linked to ovarian and breast cancer which connected with a risk of ovarian cancer of 50% and 20%, respectively. High-grade serous ovarian cancer (HGSC) frequently has lymph node involvement. According to lymphatic drainage routes, the most prevalent site of nodal metastases is in the aortic area. A case of Cancer of Unknown Primary (CUP) with abdominal lymph node enlargement and high carbohydrate antigen 125 levels discovered a germline Breast Cancer 1 (BRCA1) p.L63* variant by a family history inquiry and BRCA analysis, indicating hereditary breast and ovarian cancer syndrome. Therefore we wanted to assess whether BRCA gene status correlates with lymph node involvement in advanced stage ovarian cancer. Methods This was an analytic-observational study with cross sectional study design. The samples in this study were patients diagnosed with advanced stage ovarian cancer who were treated at M Djamil Padang General Hospital, Ibnu Sina Hospital Padang, and Ahmad Mochtar Hospital Bukittinggi by using data from BRCA somatic test results and anatomical pathology examination results. Data were being tested statistically with Chi-square/ Fischer test. Result this study showed 1 patient (3,1%) with positive pathogenic mutation detected in BRCA1 gen with lymphatic node involvement, and 8 (25%) patients without lymphatic node involvement. This study also showed 3 patients (9,4%) with negative pathogenic mutation detected in BRCA1 gen with lymphatic node involvement, and 20 (62,5%) patients without lymphatic node involvement. There is no significant correlation between BRCA mutation and lymphatic node involvement in advanced stage ovarian cancer (p=1,0). Conclusion BRCA mutation has no significant correlation with lymphatic node involvement in advanced stage ovarian cancer.
- Open Access
- 30 January 2026
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 10 (1) , 187-193
Ascites Due To Pseudomyxoma Peritonei (Pmp): A Rare Case Report
Introduction: Pseudomyxoma Peritonei (PMP), also known as "jelly-belly," is a rare condition characterized by the accumulation of mucinous ascites in the peritoneal cavity. It often originates from mucinous neoplasms of the appendix and presents with non-specific symptoms like abdominal bloating and discomfort. Diagnosis is often incidental through imaging, surgery, or histopathology. Objective: To report the diagnosis and management of PMP in a 53-year-old woman presenting with abdominal enlargement. Case Report: A 53-year-old woman was referred with a two-month history of abdominal enlargement. Initial ultrasound findings suggested ascites due to cirrhosis or ovarian carcinoma. However, further evaluation with abdominal CT revealed ascites and cholelithiasis without signs of cirrhosis or ovarian carcinoma. Diagnostic laparoscopy showed peritoneal carcinomatosis, and 8000 ml of hemorrhagic ascites was drained. Histopathological examination confirmed the diagnosis of PMP, and tissue resection was performed. Conclusion: The management of PMP requires a comprehensive diagnostic approach, incorporating clinical history, physical examination, imaging, and histopathological evaluation. This systematic approach is crucial for accurate diagnosis and effective treatment of PMP.
- 30 January 2026
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 10 (1) , 187-193
Open AccessAscites Due To Pseudomyxoma Peritonei (Pmp): A Rare Case Report
Introduction: Pseudomyxoma Peritonei (PMP), also known as "jelly-belly," is a rare condition characterized by the accumulation of mucinous ascites in the peritoneal cavity. It often originates from mucinous neoplasms of the appendix and presents with non-specific symptoms like abdominal bloating and discomfort. Diagnosis is often incidental through imaging, surgery, or histopathology. Objective: To report the diagnosis and management of PMP in a 53-year-old woman presenting with abdominal enlargement. Case Report: A 53-year-old woman was referred with a two-month history of abdominal enlargement. Initial ultrasound findings suggested ascites due to cirrhosis or ovarian carcinoma. However, further evaluation with abdominal CT revealed ascites and cholelithiasis without signs of cirrhosis or ovarian carcinoma. Diagnostic laparoscopy showed peritoneal carcinomatosis, and 8000 ml of hemorrhagic ascites was drained. Histopathological examination confirmed the diagnosis of PMP, and tissue resection was performed. Conclusion: The management of PMP requires a comprehensive diagnostic approach, incorporating clinical history, physical examination, imaging, and histopathological evaluation. This systematic approach is crucial for accurate diagnosis and effective treatment of PMP.
- Open Access
- 29 January 2026
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 10 (1) , 88-96
Relationship Between Age And Menopausal Status With The Incident Of Epithelial Ovarian Carcinoma At RSUP Dr. M. Djamil Padang
Introduction : High Grade Serous Ovarian Carcinoma (HGSOC) been the dominant subtype and accounted for the highest mortality rate of epithelial ovarian cancer. Therefore, knowledge of the risk factors for epithelial ovarian cancer was needed for early detection. Age and menopausal status were examples of risk factors. This study aimed to determine the relationship between age and menopausal status with the incidence of epithelial ovarian cancer subtype of HGSOC at M Djamil Central Hospital Padang. Method : This type of research is an observational analytic research design cross-sectional. The form sample is secondary data used in the total sampling method, which comes from 90 patients of ovarian cancer. Research in analysis univariate and bivariate presented in form table frequency. Result : In this study, it was found that epithelial ovarian cancers subtype HGSOC was found mostly in women aged > 50 years (68,9%) and who had experienced menopause (80%). In the analytic test, the p value for age and menopausal status was 0.382 and 0.104. Conclusion: Concluded there is no relationship between age and menopausal status with the incidence of epithelial ovarian cancer subtype HGSOC at M Djamil Central Hospital Padang
- 29 January 2026
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 10 (1) , 88-96
Open AccessRelationship Between Age And Menopausal Status With The Incident Of Epithelial Ovarian Carcinoma At RSUP Dr. M. Djamil Padang
Introduction : High Grade Serous Ovarian Carcinoma (HGSOC) been the dominant subtype and accounted for the highest mortality rate of epithelial ovarian cancer. Therefore, knowledge of the risk factors for epithelial ovarian cancer was needed for early detection. Age and menopausal status were examples of risk factors. This study aimed to determine the relationship between age and menopausal status with the incidence of epithelial ovarian cancer subtype of HGSOC at M Djamil Central Hospital Padang. Method : This type of research is an observational analytic research design cross-sectional. The form sample is secondary data used in the total sampling method, which comes from 90 patients of ovarian cancer. Research in analysis univariate and bivariate presented in form table frequency. Result : In this study, it was found that epithelial ovarian cancers subtype HGSOC was found mostly in women aged > 50 years (68,9%) and who had experienced menopause (80%). In the analytic test, the p value for age and menopausal status was 0.382 and 0.104. Conclusion: Concluded there is no relationship between age and menopausal status with the incidence of epithelial ovarian cancer subtype HGSOC at M Djamil Central Hospital Padang
- Open Access
- 1 September 2023
- Published by Universitas Baiturrahmah in Health and Medical Journal
- Vol. 5 (3) , 185-194
Carcinoma Endometrioid Ovary pada Struma Ovarii
Kanker ovarium merupakan penyebab utama kematian pada wanita yang didiagnosis sebagai kanker ginekologi. Tingginya angka kematian akibat kanker ovarium karena mayoritas kasus bersifat asimptomatik dan skrining yang dilakukan untuk menegakkan diagnosis masih kurang. Hal ini menyebabkan kanker ovarium dikenal sebagai silent killer. Etiologi spesifik kanker ovarium hingga belum diketahui dengan pasti, namun teradapat beberapa faktor risiko yang berperan terhadap terjadinya kanker ovarium. Faktor risiko genetik diduga berkaitan erat dengan kejadian kanker ovarium, diantaranya mutasi pada gen TP53, BRCA1 dan BRCA2. Diagnosis kanker ovarium sulit dilakukan pada stadium dini karena tidak adanya gejala spesifik. Untuk menegakkan diagnosis kanker ovarium dibutuhkan anamnesis, pemeriksaan fisik dan pemeriksaan penunjang seperti CT scan, USG, pemeriksaan tumor marker dan biopsi. Hingga saat ini, pembedahan masih menjadi penatalaksanaan utama bagi kanker ovarium. Pemeriksaan histopatologi juga perlu dilakukan untuk menentukan keganasan, jenis kanker, dan penentuan staging. Kemoterapi adjuvan diberikan pada pasien setelah pembedahan, kecuali jika penyakit hanya terbatas pada ovarium dan pada kanker yang tidak bisa dioperasi. Prognosis kanker ovarium bergantung dari jenis kanker, stadium dan komplikasi yang terjadi. Pada jurnal ini dilaporkan kasus seorang pasien perempuan, berusia 59 tahun dengan carcinoma endometrioid ovary pada struma ovarii.
- 1 September 2023
- Published by Universitas Baiturrahmah in Health and Medical Journal
- Vol. 5 (3) , 185-194
Open AccessCarcinoma Endometrioid Ovary pada Struma Ovarii
Kanker ovarium merupakan penyebab utama kematian pada wanita yang didiagnosis sebagai kanker ginekologi. Tingginya angka kematian akibat kanker ovarium karena mayoritas kasus bersifat asimptomatik dan skrining yang dilakukan untuk menegakkan diagnosis masih kurang. Hal ini menyebabkan kanker ovarium dikenal sebagai silent killer. Etiologi spesifik kanker ovarium hingga belum diketahui dengan pasti, namun teradapat beberapa faktor risiko yang berperan terhadap terjadinya kanker ovarium. Faktor risiko genetik diduga berkaitan erat dengan kejadian kanker ovarium, diantaranya mutasi pada gen TP53, BRCA1 dan BRCA2. Diagnosis kanker ovarium sulit dilakukan pada stadium dini karena tidak adanya gejala spesifik. Untuk menegakkan diagnosis kanker ovarium dibutuhkan anamnesis, pemeriksaan fisik dan pemeriksaan penunjang seperti CT scan, USG, pemeriksaan tumor marker dan biopsi. Hingga saat ini, pembedahan masih menjadi penatalaksanaan utama bagi kanker ovarium. Pemeriksaan histopatologi juga perlu dilakukan untuk menentukan keganasan, jenis kanker, dan penentuan staging. Kemoterapi adjuvan diberikan pada pasien setelah pembedahan, kecuali jika penyakit hanya terbatas pada ovarium dan pada kanker yang tidak bisa dioperasi. Prognosis kanker ovarium bergantung dari jenis kanker, stadium dan komplikasi yang terjadi. Pada jurnal ini dilaporkan kasus seorang pasien perempuan, berusia 59 tahun dengan carcinoma endometrioid ovary pada struma ovarii.
- Open Access
- 2 March 2023
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 7 (1)
Ovarian fibrosarcoma : A Case Report
This case report aims to report and discuss cases of ovarian fibrosarcoma. Ovarian fibrosarcoma is a rare casethat generally occurs in women who have menopause. In the case of ovarian fibrosarcoma, the patient was 43years old, had two children, and had no complaints during menstruation. The patient has lost weight in the lastsix months. The patient has performed debulking surgery optimally. On the PA results, it looks macroscopic, apiece of brownish-white tissue, densely rubbery, with a size of 15x12x5 cm, a solid white part is visible, and thereis a yellowish-white part and anger, there is a 0.5-1.5 cm cavity filled with a yellowish liquid. On microscopicexamination of the tumor, the tissue section appears to consist of a diffuse proliferation of tumor cells withhypercellular and hypocellular areas. Based on the results of macroscopic and microscopic examination of thetumor tissue, a skewed sarcoma is established in fibrosarcoma. The patient underwent chemotherapy after tumorsurgery. Although there is no clear consensus on the administration of fibrosarcoma chemotherapy, severalpublished case reports have demonstrated a lower probability of recurrence and a better prognosis in patientsundergoing chemotherapy.
- 2 March 2023
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 7 (1)
Open AccessOvarian fibrosarcoma : A Case Report
This case report aims to report and discuss cases of ovarian fibrosarcoma. Ovarian fibrosarcoma is a rare casethat generally occurs in women who have menopause. In the case of ovarian fibrosarcoma, the patient was 43years old, had two children, and had no complaints during menstruation. The patient has lost weight in the lastsix months. The patient has performed debulking surgery optimally. On the PA results, it looks macroscopic, apiece of brownish-white tissue, densely rubbery, with a size of 15x12x5 cm, a solid white part is visible, and thereis a yellowish-white part and anger, there is a 0.5-1.5 cm cavity filled with a yellowish liquid. On microscopicexamination of the tumor, the tissue section appears to consist of a diffuse proliferation of tumor cells withhypercellular and hypocellular areas. Based on the results of macroscopic and microscopic examination of thetumor tissue, a skewed sarcoma is established in fibrosarcoma. The patient underwent chemotherapy after tumorsurgery. Although there is no clear consensus on the administration of fibrosarcoma chemotherapy, severalpublished case reports have demonstrated a lower probability of recurrence and a better prognosis in patientsundergoing chemotherapy.
- Open Access
- 1 January 2023
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2730 (1)
Analysis of factors related to the incidence of epithelial ovarian cancer
Ovarian cancer is the seventh most common cancer and ranks eighth as the cause of death in women with cancer globally. More than 90% of all ovarian cancer incidents are ovarian cancers originating from the ovarian surface epithelium. Based on its histopathology, epithelial ovarian cancer is divided into type I and type II. The purpose of this study was to determine the relationship of age, parity, hormonal contraception, body mass index, and family history of the incidence of epithelial ovarian cancer type I and type II at RSUP Dr. M. Djamil Padang. This study was an observational analytic study with a cross-sectional approach using patients’ medical record data with epithelial ovarian cancer at RSUP Dr. M. Djamil Padang in 2017-2018. The sample in this study consisted of 100 samples, of which 50 samples for type I and 50 for type II were determined through a purposive sampling technique. Data analysis used the Kruskal-Wallis test for bivariate analysis and logistic regression test for multivariate analysis. The results of this study based on the Kruskal-Wallis test showed that age (p = 0.838), parity (p = 0.158), hormonal contraception (p = 0.118), body mass index (p = 0.082), and family history (p = 0.750) had values p> 0.05. Logistic regression test showed p-value >0.05 for all variables. So it can be concluded in this study there is no relationship between age, parity, hormonal contraception, body mass index, and family history with the incidence of epithelial ovarian cancer type I and type II.
- 1 January 2023
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2730 (1)
Open AccessAnalysis of factors related to the incidence of epithelial ovarian cancer
Ovarian cancer is the seventh most common cancer and ranks eighth as the cause of death in women with cancer globally. More than 90% of all ovarian cancer incidents are ovarian cancers originating from the ovarian surface epithelium. Based on its histopathology, epithelial ovarian cancer is divided into type I and type II. The purpose of this study was to determine the relationship of age, parity, hormonal contraception, body mass index, and family history of the incidence of epithelial ovarian cancer type I and type II at RSUP Dr. M. Djamil Padang. This study was an observational analytic study with a cross-sectional approach using patients’ medical record data with epithelial ovarian cancer at RSUP Dr. M. Djamil Padang in 2017-2018. The sample in this study consisted of 100 samples, of which 50 samples for type I and 50 for type II were determined through a purposive sampling technique. Data analysis used the Kruskal-Wallis test for bivariate analysis and logistic regression test for multivariate analysis. The results of this study based on the Kruskal-Wallis test showed that age (p = 0.838), parity (p = 0.158), hormonal contraception (p = 0.118), body mass index (p = 0.082), and family history (p = 0.750) had values p> 0.05. Logistic regression test showed p-value >0.05 for all variables. So it can be concluded in this study there is no relationship between age, parity, hormonal contraception, body mass index, and family history with the incidence of epithelial ovarian cancer type I and type II.
- Open Access
- 15 August 2022
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 6 (2)
Uterine Rupture due to Gestational Trophoblastic Neoplasia on Nulliparous Woman : A Case Report
Background : Invasive mole (IM) is a frequent complication of gestational tropoblastic neoplasia (GTN). These tissues invade the myometrium deeply, occasionally affecting the peritoneum or vaginal vault. The prevalence of an invasive mole causing uterine rupture is uncommon. Case Report : We discuss the case of a 46-year-old nulliparous woman who presented to the emergency room complained severe abdominal pain that had been present for 4 hours. Patient had a history of complete mole evacuation 2 months ago with persistently elevated beta-human chorionic gonadotropin (B-HCG). . The patient was diagnosed with suspected uterine rupture due to an invasive mole  and advised to undergo hysterectomy. Total abdominal hysterectomy was performed with the preservation of both ovaries. Choriocarcinoma was diagnosed histopathologically, and the patient was prepared for chemotherapy using EMA-CO protocols. Conclusion : Perforation of the uterus by an invasive mole is a rare but lethal complication. Although hysterectomy followed by chemotherapy is the standard treatment for this condition, several studies demonstrate the benefit of conservative management in terms of fertility preservation in reproductive-aged women.
- 15 August 2022
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 6 (2)
Open AccessUterine Rupture due to Gestational Trophoblastic Neoplasia on Nulliparous Woman : A Case Report
Background : Invasive mole (IM) is a frequent complication of gestational tropoblastic neoplasia (GTN). These tissues invade the myometrium deeply, occasionally affecting the peritoneum or vaginal vault. The prevalence of an invasive mole causing uterine rupture is uncommon. Case Report : We discuss the case of a 46-year-old nulliparous woman who presented to the emergency room complained severe abdominal pain that had been present for 4 hours. Patient had a history of complete mole evacuation 2 months ago with persistently elevated beta-human chorionic gonadotropin (B-HCG). . The patient was diagnosed with suspected uterine rupture due to an invasive mole  and advised to undergo hysterectomy. Total abdominal hysterectomy was performed with the preservation of both ovaries. Choriocarcinoma was diagnosed histopathologically, and the patient was prepared for chemotherapy using EMA-CO protocols. Conclusion : Perforation of the uterus by an invasive mole is a rare but lethal complication. Although hysterectomy followed by chemotherapy is the standard treatment for this condition, several studies demonstrate the benefit of conservative management in terms of fertility preservation in reproductive-aged women.